HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Rating of “Buy” by Analysts

HealthEquity, Inc. (NASDAQ:HQY) has been given an average rating of “Buy” by the twelve research firms that are presently covering the firm, MarketBeat Ratings reports. Twelve analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $103.83.

Several analysts have commented on HQY shares. Barrington Research restated an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a report on Friday, September 20th. KeyCorp boosted their target price on HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a report on Wednesday, June 5th. Raymond James boosted their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Friday, June 7th. JMP Securities reiterated a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the transaction, the insider now directly owns 89,769 shares of the company’s stock, valued at approximately $7,168,952.34. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, Director Frank Corvino sold 7,705 shares of the company’s stock in a transaction that occurred on Monday, July 8th. The stock was sold at an average price of $81.89, for a total transaction of $630,962.45. Following the sale, the director now directly owns 6,070 shares of the company’s stock, valued at approximately $497,072.30. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the sale, the insider now directly owns 89,769 shares in the company, valued at $7,168,952.34. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On HealthEquity

Large investors have recently added to or reduced their stakes in the stock. GM Advisory Group LLC grew its stake in shares of HealthEquity by 300.8% in the fourth quarter. GM Advisory Group LLC now owns 120,355 shares of the company’s stock worth $7,980,000 after purchasing an additional 90,329 shares in the last quarter. Forest Hill Capital LLC bought a new position in shares of HealthEquity in the fourth quarter worth $2,021,000. Norges Bank bought a new position in shares of HealthEquity in the fourth quarter worth $43,482,000. Vanguard Group Inc. grew its stake in shares of HealthEquity by 1.7% in the first quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock worth $715,783,000 after purchasing an additional 149,133 shares in the last quarter. Finally, Diversify Advisory Services LLC bought a new position in shares of HealthEquity in the first quarter worth $7,828,000. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Trading Down 1.9 %

NASDAQ:HQY opened at $80.27 on Friday. The company has a market capitalization of $6.98 billion, a PE ratio of 87.25, a price-to-earnings-growth ratio of 1.25 and a beta of 0.52. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity has a 52-week low of $61.81 and a 52-week high of $88.26. The stock has a fifty day simple moving average of $76.42 and a 200-day simple moving average of $79.21.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. On average, equities research analysts expect that HealthEquity will post 2.25 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.